FDA Seeks Comments on Reducing Regulatory and Paperwork Burdens

The Food and Drug Administration seeks input on existing regulations and related paperwork requirements that could be modified, repealed or replaced to reduce burdens on industry, it said. The effort is part of implementation of recent executive orders issued by Donald Trump on reducing and reforming regulations, FDA said. The agency seeks comments on regulations and paperwork requirements related to biologics, medical devices, drugs, foods, tobacco products and veterinary medicines, as well as regulations and paperwork requirements that may cut across several of its product-based centers.